SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Abigail B. Shoben, Kyle D. Rudser, Scott S. Emerson, More data, less information? Potential for nonmonotonic information growth using GEE, Journal of Biopharmaceutical Statistics, 2016,

    CrossRef

  2. 2
    Mohamed Mubasher, Howard E. Rockette, Stopping Rules for Long Term Clinical Trials Based on Two Consecutive Rejections of the Null Hypothesis, Communications in Statistics - Theory and Methods, 2016, 00

    CrossRef

  3. 3
    Sean S. Brummel, Daniel L. Gillen, Flexibly Monitoring Group Sequential Survival Trials When Testing is Based Upon a Weighted Log-Rank Statistic, Sequential Analysis, 2014, 33, 1, 39

    CrossRef

  4. 4
    Jing Zhou, Adeniyi Adewale, Yue Shentu, Jiajun Liu, Keaven Anderson, Information-based sample size re-estimation in group sequential design for longitudinal trials, Statistics in Medicine, 2014, 33, 22
  5. 5
    S. Haneuse, J. Schildcrout, D. Gillen, A two-stage strategy to accommodate general patterns of confounding in the design of observational studies, Biostatistics, 2012, 13, 2, 274

    CrossRef

  6. You have free access to this content6
    Jennifer C. Nelson, Andrea J. Cook, Onchee Yu, Clara Dominguez, Shanshan Zhao, Sharon K. Greene, Bruce H. Fireman, Steven J. Jacobsen, Eric S. Weintraub, Lisa A. Jackson, Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data, Pharmacoepidemiology and Drug Safety, 2012, 21,
  7. You have free access to this content7
    Andrea J. Cook, Ram C. Tiwari, Robert D. Wellman, Susan R. Heckbert, Lingling Li, Patrick Heagerty, Tracey Marsh, Jennifer C. Nelson, Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot, Pharmacoepidemiology and Drug Safety, 2012, 21,
  8. 8
    Scott S. Emerson,, Gregory P. Levin, Sarah C. Emerson, Comments on ‘Adaptive increase in sample size when interim results are promising: A practical guide with examples’, Statistics in Medicine, 2011, 30, 28
  9. 9
    Sarah C. Emerson, Kyle D. Rudser, Scott S. Emerson, Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings, Statistics in Medicine, 2011, 30, 11
  10. 10
    A. Y. Bedikian, R. C. DeConti, R. Conry, S. Agarwala, N. Papadopoulos, K. B. Kim, M. Ernstoff, Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma, Annals of Oncology, 2011, 22, 4, 787

    CrossRef

  11. 11
    Nicole L. Miller, Daniel L. Gillen, James C. Williams, Andrew P. Evan, Sharon B. Bledsoe, Fredric L. Coe, Elaine M. Worcester, Brian R. Matlaga, Larry C. Munch, James E. Lingeman, A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall’s plaque, BJU International, 2009, 103, 7
  12. 12
    Kyle D. Rudser, Scott S. Emerson, Implementing type I & type II error spending for two-sided group sequential designs, Contemporary Clinical Trials, 2008, 29, 3, 351

    CrossRef

  13. 13
    William C. Chapman, Neil Singla, Yuri Genyk, James W. McNeil, Kenneth L. Renkens, Thomas C. Reynolds, Aileen Murphy, Fred A. Weaver, A Phase 3, Randomized, Double-Blind Comparative Study of the Efficacy and Safety of Topical Recombinant Human Thrombin and Bovine Thrombin in Surgical Hemostasis, Journal of the American College of Surgeons, 2007, 205, 2, 256

    CrossRef

  14. 14
    Scott S. Emerson, John M. Kittelson, Daniel L. Gillen, Frequentist evaluation of group sequential clinical trial designs, Statistics in Medicine, 2007, 26, 28
  15. 15
    Scott S. Emerson, Issues in the use of adaptive clinical trial designs, Statistics in Medicine, 2006, 25, 19
  16. 16
    John M. Kittelson, Katrina Sharples, Scott S. Emerson, Group sequential clinical trials for longitudinal data with analyses using summary statistics, Statistics in Medicine, 2005, 24, 16
  17. 17
    Daniel L. Gillen, Scott S. Emerson, Information Growth in a Family of Weighted Logrank Statistics Under Repeated Analyses, Sequential Analysis, 2005, 24, 1, 1

    CrossRef

  18. 18
    Burton Combes, Scott S. Emerson, Nancy L. Flye, Santiago J. Munoz, Velimir A. Luketic, Marlyn J. Mayo, Timothy M. McCashland, Rowen K. Zetterman, Marion G. Peters, Adrian M. Di Bisceglie, Kent G. Benner, Kris V. Kowdley, Robert L. Carithers, Leonard Rosoff, Guadalupe Garcia-Tsao, James L. Boyer, Thomas D. Boyer, Enrique J. Martinez, Nathan M. Bass, John R. Lake, David S. Barnes, Maurizio Bonacini, Karen L. Lindsay, A. Scott Mills, Rodney S. Markin, Raphael Rubin, A. Brian West, Donald E. Wheeler, Melissa J. Contos, Alan F. Hofmann, Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis, Hepatology, 2005, 42, 5